To do so, the upregulation of T cell surface expression of CD69, PD-1 and TIGIT (51–54) within PBMC was analyzed when co-mixed with ROR1-positive MDA-MB-231 tumor cells (Figure 7). The gene discussed is CD69; the disease is neoplasm.